Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Randomized Comparison Between DES Limus Carbostent and Taxus Drug Eluting Stents in the Treatment of De-novo Coronary Lesions. The NEXT Study.

NCT01373502 is registered in ClinicalTrials.gov with CID - Carbostent & Implantable Devices as lead sponsor.

NCT NCT01373502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Randomized Comparison Between DES Limus Carbostent and Taxus Drug Eluting Stents in the Treatment of De-novo Coronary Lesions. The NEXT Study.
Lead sponsor
CID - Carbostent & Implantable Devices
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2015
Enrollment
323 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

documented silent ischemia, stable angina, unstable angina